These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38216400)

  • 1. Predictive and prognostic molecular biomarkers in lymphomas.
    Iorgulescu JB; Medeiros LJ; Patel KP
    Pathology; 2024 Mar; 56(2):239-258. PubMed ID: 38216400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A genetic profiling guideline to support diagnosis and clinical management of lymphomas.
    Sánchez-Beato M; Méndez M; Guirado M; Pedrosa L; Sequero S; Yanguas-Casás N; de la Cruz-Merino L; Gálvez L; Llanos M; García JF; Provencio M
    Clin Transl Oncol; 2024 May; 26(5):1043-1062. PubMed ID: 37672206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New developments in non-Hodgkin lymphoid malignancies.
    Ganapathi KA; Brown LE; Prakash S; Bhargava P
    Pathology; 2021 Apr; 53(3):349-366. PubMed ID: 33685720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular abnormalities in lymphomas].
    Delsol G
    Bull Cancer; 2010 Nov; 97(11):1347-64. PubMed ID: 21084243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRD Detection in B-Cell Non-Hodgkin Lymphomas Using Ig Gene Rearrangements and Chromosomal Translocations as Targets for Real-Time Quantitative PCR.
    Pott C; Brüggemann M; Ritgen M; van der Velden VHJ; van Dongen JJM; Kneba M
    Methods Mol Biol; 2019; 1956():199-228. PubMed ID: 30779036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [R.E.A.L. classification of non-Hodgkin lymphoma from the clinico-oncologic viewpoint].
    Meusers P; Brittinger G
    Praxis (Bern 1994); 1998 Jun; 87(23):793-800. PubMed ID: 9654985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update on genetic aberrations in T-cell neoplasms.
    Parilla M; Quesada AE; Medeiros LJ; Thakral B
    Pathology; 2023 Apr; 55(3):287-301. PubMed ID: 36801152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical utility of recently identified diagnostic, prognostic, and predictive molecular biomarkers in mature B-cell neoplasms.
    Onaindia A; Medeiros LJ; Patel KP
    Mod Pathol; 2017 Oct; 30(10):1338-1366. PubMed ID: 28664939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The World Health Organization classification of malignant lymphoma: incidence and clinical prognosis in HTLV-1-endemic area of Fukuoka.
    Ohshima K; Suzumiya J; Kikuchi M
    Pathol Int; 2002 Jan; 52(1):1-12. PubMed ID: 11940200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution and ZAP-70 expression of WHO lymphoma categories in Shanxi, China: a review of 447 cases using a tissue microarray technique.
    Wang J; Young L; Win W; Taylor CR
    Appl Immunohistochem Mol Morphol; 2005 Dec; 13(4):323-32. PubMed ID: 16280661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathology consultation on intermediate-to-large B-cell lymphomas.
    Montgomery ND; Fedoriw Y
    Am J Clin Pathol; 2014 Mar; 141(3):305-17. PubMed ID: 24515757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ESMO consensus conference on malignant lymphoma: general perspectives and recommendations for prognostic tools in mature B-cell lymphomas and chronic lymphocytic leukaemia.
    Ladetto M; Buske C; Hutchings M; Dreyling M; Gaidano G; Le Gouill S; Luminari S; Pott C; Zamò A; Zucca E;
    Ann Oncol; 2016 Dec; 27(12):2149-2160. PubMed ID: 27701070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression profiles of MYC protein and MYC gene rearrangement in lymphomas.
    Chisholm KM; Bangs CD; Bacchi CE; Molina-Kirsch H; Cherry A; Natkunam Y
    Am J Surg Pathol; 2015 Mar; 39(3):294-303. PubMed ID: 25581730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive histopathological diagnostics of aggressive B-cell lymphomas based on the updated criteria of the World Health Organisation's 2017 classification.
    Szumera-Ciećkiewicz A; Rymkiewicz G; Grygalewicz B; Jesionek-Kupnicka D; Gruchała A; Ziarkiewicz-Wróblewska B; Gałązka K; Reszeć J; Borg K; Prochorec-Sobieszek M
    Pol J Pathol; 2018; 69(1):1-19. PubMed ID: 29895122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathology of malignant lymphomas--clarity instead of confusion].
    Mueller-Garamvölgyi E; Perren A; Schmitt A
    Ther Umsch; 2010 Oct; 67(10):497-500. PubMed ID: 20886454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive genomic profiling of orbital and ocular adnexal lymphomas identifies frequent alterations in MYD88 and chromatin modifiers: new routes to targeted therapies.
    Cani AK; Soliman M; Hovelson DH; Liu CJ; McDaniel AS; Haller MJ; Bratley JV; Rahrig SE; Li Q; Briceño CA; Tomlins SA; Rao RC
    Mod Pathol; 2016 Jul; 29(7):685-97. PubMed ID: 27102345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics and Diagnostic Approach to Lymphoblastic Leukemia/Lymphoma.
    Afkhami M; Ally F; Pullarkat V; Pillai RK
    Cancer Treat Res; 2021; 181():17-43. PubMed ID: 34626353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCR-ABL1-like B-Lymphoblastic Leukemia/Lymphoma with FOXP1-ABL1 Rearrangement: Comprehensive Laboratory Identification Allowing Tyrosine Kinase Inhibitor Use.
    Yenamandra AK; Kaviany S; Borinstein SC; Friedman DL; Kovach AE
    Lab Med; 2019 Oct; 50(4):401-405. PubMed ID: 30938769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome.
    Li S; Lin P; Fayad LE; Lennon PA; Miranda RN; Yin CC; Lin E; Medeiros LJ
    Mod Pathol; 2012 Jan; 25(1):145-56. PubMed ID: 22002575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Grey zone lymphomas: limitations of the classification of aggressive B-cell lymphomas].
    Ott MM; Horn H; Rosenwald A; Ott G
    Pathologe; 2013 May; 34(3):225-32. PubMed ID: 23494279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.